NEO Investors Have Opportunity to Lead NeoGenomics, Inc. Securities Fraud Lawsuit

4:58 pm ET January 20, 2023 (PR Newswire) Print

The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ: NEO).

Class Period: February 27, 2020 - April 26, 2022Lead Plaintiff Deadline: February 6, 2023

If you are a shareholder who suffered a loss, click here to participate.

The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investorsthat: (1) NeoGenomics was anything but a "one-stop-shop" for cancer testing because it did not offer the most technologically advanced NGS tests, which led to a significant decrease in revenue as current and prospective customers went elsewhere for their testing needs; (2) the Company's costs were not fixed because NeoGenomics needed to hire additional employees to process more complex customized testing demanded by customers utilizing the Company's outdated portfolio of tests, leading to operational challenges, decreased lab efficiency, and increased testing turnaround times; (3) NeoGenomics violated federal healthcare laws and regulations related to fraud, waste, and abuse; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, 310-914-5007fcruz@frankcruzlaw.comwww.frankcruzlaw.com

https://c212.net/c/img/favicon.png?sn=LA92849&sd=2023-01-20

View original content:https://www.prnewswire.com/news-releases/neo-investors-have-opportunity-to-lead-neogenomics-inc-securities-fraud-lawsuit-301727161.html

SOURCE The Law Offices of Frank R. Cruz, Los Angeles

https://rt.newswire.ca/rt.gif?NewsItemId=LA92849&Transmission_Id=202301201658PR_NEWS_USPR_____LA92849&DateId=20230120

COMTEX_423003565/1005/2023-01-20T16:58:10